Research indicates that patients with Child-Pugh Class A cirrhosis (mild) often tolerate GLP-1 therapy with monitoring, while Class B and C (moderate to severe) carry elevated risk for hypoglycemia, drug accumulation, and worsening fluid retention
Weekly Support Groups Live Zoom sessions with peers on the same journey
J Diabetes Sci Technol 15(4):786791 Deiss D, Irace C, Carlson G, Tweden KS, Kaufman FR (2020) Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: a post-market registry study
If you are not doing anything, the drug carries more of the load, and the risks of dependency and rebound become more relevant
10.1002/biof.195 147 JuJ.WangC.QiaoY.LiD.LiW
Can be used on slightly damp skin for enhanced absorption